| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 115,55 | 116,20 | 20:24 | |
| 115,55 | 116,20 | 20:24 |
Das irische Pharmaunternehmen trotzt der allgemein schwachen Entwicklung der Wall Street und zeigt seit geraumer Zeit Relative Stärke gegenüber dem Gesamtmarkt.Den vollständigen Artikel lesen ...| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Jazz Pharmaceuticals up as Q3 results beat on both lines, adjusts 2025 guidance | ||
| Mi | Jazz Pharmaceuticals Plc Reveals Advance In Q3 Bottom Line | WASHINGTON (dpa-AFX) - Jazz Pharmaceuticals plc (JAZZ) reported earnings for its third quarter that Increases, from the same period last yearThe company's bottom line totaled $251.4 million... ► Artikel lesen | |
| Mi | Jazz Pharmaceuticals Non-GAAP EPS of $8.13 beats by $2.28, revenue of $1.13B beats by $20M | ||
| Mi | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces Third Quarter 2025 Financial Results and Updates 2025 Financial Guidance | - Modeyso approved as the first and only treatment for recurrent H3 K27M-mutant DMG -
- Zepzelca® and atezolizumab (Tecentriq®) combination approved as maintenance therapy in 1L ES-SCLC... ► Artikel lesen | |
| Mi | Jazz Pharmaceuticals plc - 10-Q, Quarterly Report |
